Vibrations: Vibration Building Design for Cancer Center Part 1

Critical industries need building infrastructure that eliminates even the slightest whisper of the wind or rumblings of public transit miles away. Sensitive instruments used in mission-critical research, testing, and product equipment must exist in a vibration-free environment. Industry-leading TCM understands these needs, and their products have become an essential tool for vibration control to solve building vibration challenges. Ahmad Bayat, P.E., President at Vibro-Acoustic Consultants, and Mike Georgalis, North American Sales Manager at the Technical Manufacturing Corporation (TMC), joined Vibrations’ host, Daniel J. Litwin, for an in-depth 3-part discussion on vibration control strategies and technologies, including insight on a recent Cancer research lab project with a challenging micro-vibration design. In this first episode, Bayat and Georgalis laid the foundation for understanding mission-critical environments’ challenges with building vibrations.

“The world of micro and nano-scale that involves not only life sciences but in many of the industries where R&D is needed, besides the manufacturing and production, it’s migrated to nano-scale these days,” Bayat said. “Not only scientists are looking at the subatomic structure of a cancer cell, or it could be a semiconductor component, but on top of that, they are looking at and manipulating the atomic and subatomic structure. So, the challenge for all of us is to make precision tools operate successfully to allow the scientists to perform what they need to do in terms of manipulating and analyzing different species.” And in this case study, the precision needed involves cancer cells.

To conquer this world of vibrations at a nano-scale level may pose challenges. Still, they’re ones Bayat and Georgalis enjoy taking on no matter the industry requiring such cutting-edge technology.

“These types of problems are common problems, and they need to be solved in different places around the world and in a lot of different industries,” Georgalis said. “A good example is in the semiconductor industry where the big microchip manufacturers are pushing the limits to how small a microchip they can make.” These chips require manufacturing conditions without vibrations, and thus these companies rely on partners like TCM to create vibrationless solutions.

Follow us on social media for the latest updates in B2B!

Image

Latest

Texas
Up Next: Demographic Change, Education, and the Future of Texas and the Nation
December 2, 2025

Houston’s unmatched diversity and rapidly growing young population are reshaping the city’s economic future — and offering clues about what’s ahead for the nation. In the upcoming episode of Weaver: Beyond the Numbers, the conversation explores how immigration, education, and demographic momentum intersect to create extraordinary opportunities when supported with the right investments.

Read More
patient
Rebecca Interview: When Peer-to-Peer Reviews Stop Being About the Patient
December 2, 2025

Behind the sterile labels of “inpatient” versus “observation” care is a messy reality: clinicians and insurers often enter peer-to-peer reviews without a shared rulebook, turning what should be a clinical dialogue into a box-checking exercise. The speaker’s frustration points to a broader problem in U.S. healthcare utilization management—decisions about coverage can feel pre-decided,…

Read More
physician advisor
Navigating Payer Denials: A Physician Advisor’s Perspective #2
December 2, 2025

A physician advisor recently described a case that should unsettle anyone who cares about fair, clinically grounded coverage decisions: a Medicaid patient arrived comatose from an overdose, was emergently intubated, developed aspiration pneumonia, and stayed through three midnights before leaving against medical advice. By any bedside standard, this is acute, unstable care—exactly what…

Read More
Navigating Payer Denials: A Physician Advisor’s Perspective #1
December 2, 2025

America’s healthcare system is buckling under a contradiction we’ve normalized: we expect reliable care for roughly 380 million people while letting every major lever of the system be pulled by for-profit players chasing the same dollar. In any market, companies will optimize for profit, but in medicine that instinct collides with a rulebook…

Read More